3rd Quarter 2017
Key topics in this quarter’s edition include:
- Ataluren: for protein restoration therapy for the treatment of nonsense mutation Duchenne muscular dystrophy
- Copanlisib: treatment of relapsed or refractory follicular lymphoma in patients who have received at least 2 prior therapies
- Semaglutide: as an adjunct to diet and exercise for the treatment of type 2 diabetes mellitus
Top